Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
2.
Microb Pathog ; 177: 106050, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36842516

RESUMEN

The objective of the study was to establish the incidence, pathogenic factors and antimicrobial resistance of Vibrio parahaemolyticus in seafood from retail shops in Bulgaria. A hundred and eighty samples of sea fish, mussels, oysters, veined rapa whelks, shrimps and squids were included in the study. PCR methods were used to identify V. parahaemolyticus and prove tdh and trh genes. Antimicrobial resistance was established by disc diffusion method, and MAR index was calculated. The results proved the presence of V. parahaemolyticus in 24% (44/180) of the seafood samples. tdh-positive V. parahaemolyticus was not found, while the trh gene was detected in one veined rapa whelk isolate. All isolates were susceptible to Sulfamethoxazole/trimethoprim, Tetracycline, Gentamycin, Amoxicillin-clavulanic acid, Amikacin, Ciprofloxacin, and Levofloxacin. Intermediate resistance was found to Ampicillin (25%; 11/44), Cefepime (16%; 7/44), and Ceftazidime (2%; 1/44). The results showed that 16% (7/44) of the isolates were resistant to Cefepime, 9% (4/44) to Ampicillin, and 5% (2/44) to Ceftazidime. MAR-index values ranged from 0.10 to 0.30. The incidence of pathogenic and multidrug-resistant V. parahaemolyticus strains in seafood offered on the market poses a risk to consumer health.


Asunto(s)
Vibrio parahaemolyticus , Animales , Antibacterianos/farmacología , Virulencia/genética , Cefepima , Ceftazidima , Incidencia , Farmacorresistencia Bacteriana/genética , Ampicilina , Alimentos Marinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA